Product NDC: | 54738-903 |
Proprietary Name: | Sulindac |
Non Proprietary Name: | Sulindac |
Active Ingredient(s): | 200 mg/1 & nbsp; Sulindac |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54738-903 |
Labeler Name: | Richmond Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072051 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090904 |
Package NDC: | 54738-903-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (54738-903-01) |
NDC Code | 54738-903-01 |
Proprietary Name | Sulindac |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (54738-903-01) |
Product NDC | 54738-903 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sulindac |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090904 |
Marketing Category Name | ANDA |
Labeler Name | Richmond Pharmaceuticals |
Substance Name | SULINDAC |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |